Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-27

Clinical Trial Update: Effect of Tranexamic Acid and Calcium Dobesilate for Bleeding of Endometrial Origin [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating tranexamic acid in combination with calcium dobesilate for endometrial-origin bleeding has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium dobesilate (calcium dobesilate)
  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: District Headquarters Teaching Hospital Sahiwal | Conditions: Heavy. Mentrual Bleeding, Abormal utèrine Bleeding | Phase 2, Phase 3 | Status: COMPLETED